Scholar Rock to Present Clinical and Biomarker Data from the

Poster presentations to include safety, efficacy, and biomarker data from Part A and B of the DRAGON trial in patients with advanced solid tumors treated with SRK-181


...

Related Keywords

Texas , United States , Jay Backstrom , Timothy Yap , Susan Henry , San Diego Convention Center , Exchange Commission , University Of Texas Md Anderson Cancer Center , Translational Sciences , Twitter , Department Of Investigational Cancer Therapeutics , Linkedin , Scholar Rock Inc , Society For Immunotherapy Of Cancer , Scholar Rock , Annual Meeting , San Diego , Chief Executive Officer , Establishing Proof , Preliminary Biomarker Data , Senior Director , Exhibit Halls , Medical Oncologist , Associate Professor , Investigational Cancer Therapeutics , Securities Act , Private Securities Litigation Reform Act , Quarterly Report , Markets ,